Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

This publication has 44 references indexed in Scilit:

• The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis
  Journal of Biological Chemistry, 1997
• Activation of NFκB Is Essential but Not Sufficient to Stimulate Mitogenesis of Vascular Smooth Muscle Cells
  Biochemical and Biophysical Research Communications, 1997
• Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.
  Journal of Clinical Investigation, 1995
• Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell Activation
  Biochemical and Biophysical Research Communications, 1995
• Lovastatin Inhibits Proliferation and Differentiation and Causes Apoptosis in Lipopolysaccharide-Stimulated Murine B Cells
  Biochemical and Biophysical Research Communications, 1995
• Function and Activation of NF-kappaB in the Immune System
  Annual Review of Immunology, 1994
• HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)
  Atherosclerosis, 1992
• A macrophage LPS-inducible early gene encodes the murine homologue of IP-10
  Biochemical and Biophysical Research Communications, 1990
• Regulation of the mevalonate pathway
  Nature, 1990